• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX-FX05RW
Device Problem Increase in Pressure (1491)
Patient Problem No Information (3190)
Event Date 10/31/2018
Event Type  Injury  
Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.510(k) no: k130280.The actual device was returned for evaluation.Visual inspection upon receipt revealed no anomaly, such as a break, in the appearance.The actual device was fixed with glutaraldehyde solution.The housing and filter were removed from the oxygenator module.Visual inspection of the filter did not reveal any clot formation visible to the unaided eye either on the outer or inner surface.Visual inspection of the oxygenator module, after the housing and filter having been removed from it, did not reveal any cot formation visible to the unaided eye on the fiber.The fiber winding was confirmed to be in the normal state.The fiber layer was removed from the winding in increments of 2mm and each layer was subjected to visual inspection.Some clots were found to have formed on the fiber layers located close to the heat exchanger module.The fiber and the outer cylinder were removed from the heat exchanger module and the inside of the heat exchanger module was subjected to visual and magnifying inspections.No clot formation was confirmed.The filter removed from the oxygenator module in the above inspection was inspected under magnification and revealed no clot formation.The diameter of the mesh of the filter was confirmed to be normal.The fiber layers removed during the above test were inspected under magnification.Some clots were found to have formed on the fiber layers located on 8mm from the outmost circumference to the last layer on the heat exchanger.The filter was inspected under electron microscope.The adhesion of the erythrocyte components, including platelets, were found on the surface.Electron microscopic inspection of the fiber on each layer on the upper side of the fiber winding obtained in above inspection revealed no clot formation which could have contributed to the pressure rise.A review of the device history record of the involved product code/lot number combination revealed no findings.There is no evidence that this event was related to a device defect or malfunction.During the inspection of the actual device, some platelets were found to be adhering to the oxygenator module.However, it cannot be determined if this has any cause-and-effect relationship with the reported complaint.The ifu states: "do not reduce heparin during circulation.Otherwise, blood clotting might occur.Adequate heparinization of the blood is required to prevent it from clotting in the system." (b)(4).
 
Event Description
The user facility reported that soon after the initiation of the extracorporeal circulation, there was a rise in the pressure before the membrane was noted when using the involved capiox device.The pressure went up higher than the alarming value of 500 mmhg.The actual sample was changed out.Blood loss was reported to be 43 ml.The procedure outcome is unknown.The final patient impact is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
mark vornheder
reg. no. 2243441
950 elkton blvd
elkton, MD 21921
MDR Report Key8077106
MDR Text Key127340586
Report Number9681834-2018-00204
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071572
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2021
Device Catalogue NumberCX-FX05RW
Device Lot Number180702
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/01/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/31/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/02/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-